SE9102909D0 - New use - Google Patents

New use

Info

Publication number
SE9102909D0
SE9102909D0 SE9102909A SE9102909A SE9102909D0 SE 9102909 D0 SE9102909 D0 SE 9102909D0 SE 9102909 A SE9102909 A SE 9102909A SE 9102909 A SE9102909 A SE 9102909A SE 9102909 D0 SE9102909 D0 SE 9102909D0
Authority
SE
Sweden
Prior art keywords
pct
date apr
compound
sec
salt
Prior art date
Application number
SE9102909A
Other languages
English (en)
Other versions
SE469368B (sv
SE9102909L (sv
Inventor
O Abramsky
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9102909A priority Critical patent/SE469368B/sv
Publication of SE9102909D0 publication Critical patent/SE9102909D0/sv
Priority to US08/211,579 priority patent/US5580882A/en
Priority to PT100937A priority patent/PT100937A/pt
Priority to CA002120712A priority patent/CA2120712A1/en
Priority to EP92921605A priority patent/EP0607282A1/en
Priority to PCT/SE1992/000705 priority patent/WO1993006829A1/en
Priority to JP5506847A priority patent/JPH06511488A/ja
Priority to AU27708/92A priority patent/AU653647B2/en
Priority to KR1019940701161A priority patent/KR940702726A/ko
Publication of SE9102909L publication Critical patent/SE9102909L/sv
Publication of SE469368B publication Critical patent/SE469368B/sv
Priority to NO941273A priority patent/NO941273L/no
Priority to EE9400257A priority patent/EE9400257A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9102909A 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms) SE469368B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)
KR1019940701161A KR940702726A (ko) 1991-10-09 1992-10-08 치환된 퀴놀린-3-카르복시아미드 화합물의 용도 및 이를 이용한 다발성 경화증의 치료방법
EP92921605A EP0607282A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
PT100937A PT100937A (pt) 1991-10-09 1992-10-08 Composicoes farmaceuticas contendo novas carboxamidas de quinolina susbstituidas
CA002120712A CA2120712A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
US08/211,579 US5580882A (en) 1991-10-09 1992-10-08 Use of substituted quinoline carboxamide
PCT/SE1992/000705 WO1993006829A1 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
JP5506847A JPH06511488A (ja) 1991-10-09 1992-10-08 置換キノリンカルボキシアミドの新規な使用
AU27708/92A AU653647B2 (en) 1991-10-09 1992-10-08 New use of substituted quinoline carboxamide
NO941273A NO941273L (no) 1991-10-09 1994-04-08 Ny anvendelse av substituert kinolinkarboksamid
EE9400257A EE9400257A (et) 1991-10-09 1994-11-17 Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Publications (3)

Publication Number Publication Date
SE9102909D0 true SE9102909D0 (sv) 1991-10-09
SE9102909L SE9102909L (sv) 1993-04-10
SE469368B SE469368B (sv) 1993-06-28

Family

ID=20383935

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Country Status (11)

Country Link
US (1) US5580882A (sv)
EP (1) EP0607282A1 (sv)
JP (1) JPH06511488A (sv)
KR (1) KR940702726A (sv)
AU (1) AU653647B2 (sv)
CA (1) CA2120712A1 (sv)
EE (1) EE9400257A (sv)
NO (1) NO941273L (sv)
PT (1) PT100937A (sv)
SE (1) SE469368B (sv)
WO (1) WO1993006829A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302490D0 (sv) * 1993-07-26 1993-07-26 Kabi Pharmacia Ab New use of old drugs
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
EP0685466A1 (de) * 1994-06-02 1995-12-06 Ciba-Geigy Ag 3-Heteroaliphatyl- und 3-Hetero-(aryl)aliphatyl-2(1H)-chinolonderivate
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
WO1998018326A1 (en) * 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
JP4120713B2 (ja) * 1997-09-04 2008-07-16 大塚製薬株式会社 多発性硬化症治療剤
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
WO2012050500A1 (en) 2010-10-14 2012-04-19 Lars Pettersson 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide

Also Published As

Publication number Publication date
EP0607282A1 (en) 1994-07-27
JPH06511488A (ja) 1994-12-22
AU2770892A (en) 1993-05-03
NO941273D0 (no) 1994-04-08
NO941273L (no) 1994-06-08
WO1993006829A1 (en) 1993-04-15
US5580882A (en) 1996-12-03
KR940702726A (ko) 1994-09-17
PT100937A (pt) 1994-01-31
SE469368B (sv) 1993-06-28
AU653647B2 (en) 1994-10-06
CA2120712A1 (en) 1993-04-15
SE9102909L (sv) 1993-04-10
EE9400257A (et) 1996-02-15

Similar Documents

Publication Publication Date Title
BR1100086A (pt) Derivados de fluoralcóxibenzilamino de heterocìclos contendo nitrogênio
SE9102909D0 (sv) New use
ES8600288A1 (es) Un procedimiento para la preparacion de derivados de quinolina.
SE9302490D0 (sv) New use of old drugs
DE69428142D1 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
MY113266A (en) New indol derivatives derivatives with high affinity 5-ht1a receptor.
ATE204272T1 (de) Neue pyridon carbonsäure-derivate
SE9400809D0 (sv) New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) New use of Quinoline-3-carboxamide compounds
SE9201076D0 (sv) The use of old drugs for the treatment of diabetes
NO870423L (no) 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter.
DE69509231T2 (de) 3-substituierte pyridinverbindungen und deren derivate als herbizide
HUP9900895A2 (hu) Simaizom sejtburjánzást gátló 2-szubsztituált benzimidazolszármazékok
GEP19970835B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
ES463570A1 (es) Un procedimiento para la preparacion de nuevos compuestos triciclicos biologicamente activos
SE7811478L (sv) Substituerade tiofener
GEP19970838B (en) Process for obtaining 3-(methyltio, methylsulphinyl or methylsulphonyl)-4-quinolone
MX9802932A (es) Derivados de azaindol-etilamina como agentes que se unen al receptor nicotinico de la acetilcolina.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 9102909-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 9102909-0

Format of ref document f/p: F